Lisata Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LSTA and other ETFs, options, and stocks.About LSTA
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors.
CEODavid J. Mazzo
CEODavid J. Mazzo
Employees26
Employees26
HeadquartersBasking Ridge, New Jersey
HeadquartersBasking Ridge, New Jersey
Founded1980
Founded1980
Employees26
Employees26
LSTA Key Statistics
Market cap17.79M
Market cap17.79M
Price-Earnings ratio-0.96
Price-Earnings ratio-0.96
Dividend yield—
Dividend yield—
Average volume24.26K
Average volume24.26K
High today$2.05
High today$2.05
Low today$1.94
Low today$1.94
Open price$1.94
Open price$1.94
Volume25.41K
Volume25.41K
52 Week high$4.20
52 Week high$4.20
52 Week low$1.81
52 Week low$1.81
Stock Snapshot
As of today, Lisata Therapeutics(LSTA) shares are valued at $1.97. The company's market cap stands at 17.79M, with a P/E ratio of -0.96.
As of 2025-12-05, Lisata Therapeutics(LSTA) stock has fluctuated between $1.94 and $2.05. The current price stands at $1.97, placing the stock +1.5% above today's low and -3.9% off the high.
Lisata Therapeutics(LSTA) shares are trading with a volume of 25.41K, against a daily average of 24.26K.
In the last year, Lisata Therapeutics(LSTA) shares hit a 52-week high of $4.20 and a 52-week low of $1.81.
In the last year, Lisata Therapeutics(LSTA) shares hit a 52-week high of $4.20 and a 52-week low of $1.81.
People also own
Based on the portfolios of people who own LSTA. This list is generated using Robinhood data, and it’s not a recommendation.